GlaxoSmithKline PLC (LSE:GSK) - Share price - Overview

Not a customer yet?

Buy shares from £4.95 with our easy-to-use SIPPs, ISAs and Dealing accounts

Find out more

Stock Report

GlaxoSmithKline PLC GSK

Last Price
GBX1,678.00

Day Change
-10.50|-0.62%

As of 21/03/2017
15:10:16 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,688.50p
Day Range1,675.90 - 1,689.00
Mkt Cap82.91Bil
52-Wk Range1,363.00 - 1,745.56
Yield %4.77
ISINGB0009252882
Volume3,086,320
P/E50.66
P/S2.92
P/CF13.88

Share Price

Total Returns 20/03/2017

 Chg (%)  
More ...
GlaxoSmithKline PLC4.58 
FTSE 100 TR GBP2.38
 
Financials
201420152016
More ...
Income Statement
Turnover23,006.0023,923.0027,889.00
Operating Profit3,597.0010,322.002,598.00
Net Profit2,831.008,372.001,062.00
Reported EPS56.70172.3018.60
Balance Sheet
Current Assets13,522.0016,541.0016,496.00
Non Current Assets25,973.0036,859.0042,370.00
Total Assets40,651.0053,446.0059,081.00
Current Liabilities13,295.0013,417.0019,001.00
Total Liabilities35,715.0044,568.0054,118.00
Total Equity4,936.008,878.004,963.00
Cash Flow
Operating Cash Flow6,284.004,631.008,106.00
Net Change in Cash-1,287.001,503.00-1,164.00
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
15/03/2017PurchaseDr Moncef Slaoui1,727.508138.00
15/03/2017PurchaseDr Moncef Slaoui1,727.501823,144.00
09/03/2017PurchaseSir Andrew Witty1,673.207117.00
09/03/2017Transfer inSir Andrew Witty0.0070.00

Company Profile

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Sector

Drug Manufacturers - Major

Market Position

5 of 1852 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE Eurotop 100 ,S&P Europe 350 ,Eurotop 300

Outlook

(14/03/2017) ceo - "I expect the group to make continued progress in 2017"

Next Event 13/04/2017

Dividend Payment
Ratios
CompSecMkt
More ...
PER (E)0.0014.0116.31
Div Yld (E)0.000.814.25
PEG (E)0.000.301.01
ROCE58.42326.92-16.75
Op Mrgn25.81-8.48-22.72
EPS Grwth0.0067.4943.19
Dividends
PreviousLatest
More ...
Record Date04/11/1624/02/17
Ex-Div03/11/1623/02/17
Paid12/01/1713/04/17
Amnt19.0023.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Philip Hampton
Chief Executive OfficerSir Andrew Witty
Chief Financial OfficerMr. Simon Dingemans
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.